Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP4 | P49662 | 1/20 | 0.32 |
| ▸ | CASP5 | P51878 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3584221 | 0.91 | — | — | |
| SCHEMBL17080990 | 0.78 | — | — | |
| SCHEMBL24911819 | 0.72 | ALDH1A1 (0.34) | USP2HTR2CALDH1A1MAPTHRH4 | |
| SCHEMBL22530438 | 0.70 | HTR2C (0.36) | HTR2CHTR2BALDH1A1 | |
| SCHEMBL10437043 | 0.68 | SMN1; SMN2 (0.43) | USP2SMN1; SMN2TDP1HTR2CHTR2B | |
| SCHEMBL24710915 | 0.68 | ALDH1A1 (0.36) | ALDH1A1MAPT | |
| SCHEMBL23486255 | 0.67 | ALDH1A1 (0.35) | USP2TDP1ALDH1A1MAPTINMT | |
| SCHEMBL6699994 | 0.67 | ALDH1A1 (0.35) | USP2TDP1ALDH1A1MAPTINMT | |
| SCHEMBL23661069 | 0.67 | ALDH1A1 (0.35) | USP2TDP1ALDH1A1MAPTINMT | |
| SCHEMBL8420655 | 0.67 | ALDH1A1 (0.35) | USP2TDP1ALDH1A1MAPTINMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3310825-B1 | TWO-PART POLYURETHANE ADHESIVES MADE USING ISOCYANATE-TERMINATED QUASI-PREPOLYMERS BASED ON POLY (BUTYLENE OXIDE) | DDP SPECIALTY ELECTRONIC MATERIALS US LLC (US) | 2022-06-22 | — | — | EP | disclosed |
| US-10428251-B2 | Two-part polyurethane adhesives made using isocyanate-terminated quasi-prepolymers based on poly(butylene oxide) | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20180155590-A1 | TWO-PART POLYURETHANE ADHESIVES MADE USING ISOCYANATE-TERMINATED QUASI-PREPOLYMERS BASED ON POLY(BUTYLENE OXIDE) | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-07 | — | — | US | disclosed |
| EP-3310825-A1 | TWO-PART POLYURETHANE ADHESIVES MADE USING ISOCYANATE-TERMINATED QUASI-PREPOLYMERS BASED ON POLY (BUTYLENE OXIDE) | Dow Global Technologies LLC (US) | 2018-04-25 | — | — | EP | disclosed |
| WO-2016204978-A1 | TWO-PART POLYURETHANE ADHESIVES MADE USING ISOCYANATE-TERMINATED QUASI-PREPOLYMERS BASED ON POLY (BUTYLENE OXIDE) | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-22 | — | — | WO | disclosed |
| EP-1738737-B1 | Dimensionally stable articles from cured condensation-crosslinked dental material | KETTENBACH GMBH & CO KG (DE) | 2012-05-16 | — | — | EP | disclosed |
| US-7790781-B2 | Condensation-crosslinkable dental material hardening to dimensionally stable casts | KETTENBACH GMBH & CO. KG (DE) | 2010-09-07 | — | — | US | disclosed |
| US-7514201-B2 | Positive photosensitive composition | FUJIFILM CORPORATION (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20070141513-A1 | Positive photosensitive composition | FUJI PHOTO FILM CO., LTD. | 2007-06-21 | — | — | US | disclosed |
| US-20070004821-A1 | Condensation-crosslinked dental material hardening to dimensionally stable casts | KETTENBACH GMBH & CO. KG | 2007-01-04 | — | — | US | disclosed |
| EP-1738737-A1 | Dimensionally stable articles from cured condensation-crosslinked dental material | Kettenbach GmbH & CO. KG (DE) | 2007-01-03 | — | — | EP | disclosed |
| EP-1474411-A2 | IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES | Abbott Laboratories (US) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003068765-A2 | IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES | ABBOTT LABORATORIES (US) | 2003-08-21 | — | — | WO | disclosed |
| US-20030153773-A1 | Process for the production of dihydropyridines | ABBOTT LABORATORIES | 2003-08-14 | — | — | US | disclosed |
| US-6316652-B1 | MITOPLATIN METAL COMPLEXES THAT ARE CISPLATIN DERIVATIVES; ANTITUMOR, ANTICARCINOGENIC, ANTIDIABETIC AND ANTIARTHRITIC AGENTS | STELIOU, KOSTA | 2001-11-13 | — | — | US | disclosed |
| EP-0831918-A2 | DRUG MITOCHONDRIAL TARGETING AGENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996039193-A2 | DRUG MITOCHONDRIAL TARGETING AGENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-12-12 | — | — | WO | disclosed |
| EP-0624591-A1 | Organosilicon compounds with cage structure | Wacker-Chemie GmbH (DE) | 1994-11-17 | — | — | EP | disclosed |
| US-4391626-A | PLANT SAFENING AGENTS FOR USE WITH THIOLCARBAMATES AND ACETANILIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030153773-A1 | Process for the production of dihydropyridines | QDPR, DHPS, FDPS | USP2 3542/4885SMN1; SMN2 4329/4885TDP1 2474/4885 |
| US-20070004821-A1 | Condensation-crosslinked dental material hardening to dimensionally stable casts | SMCHD1, SMC1A, SMC2 | USP2 2860/4885SMN1; SMN2 2843/4885TDP1 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.